David LinetskyPoint-of-Care Marketing
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
SOUTH SAN FRANCISCO, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...
—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email